ContextVision AB (publ) is a Swedish medical technology software company founded in 1983, specializing in image analysis and artificial intelligence solutions for healthcare imaging. It develops proprietary software that enhances image quality in medical systems, including 2D/3D/4D ultrasound, X-ray, radiography, mammography, and MRI, enabling faster and more reliable diagnostics across fields like radiology, cardiology, women's health, and point-of-care applications. Notable platforms include Rivent for ultrasound image enhancement and Altumira for scatter correction in radiography, which supports radiation dose reduction while improving clarity. As a global market leader, ContextVision partners with leading original equipment manufacturers (OEMs), with its solutions installed in over 400,000 systems worldwide. The company maintains a strong focus on research and development, employing around 44 people, half dedicated to innovation, and operates across Asia, Europe, and America with local presence in key markets like the U.S., Japan, China, and South Korea. Recent strategic collaborations, such as with the University of Washington and University of Waterloo, advance AI-driven diagnostics for liver diseases like MASLD, underscoring its role in transforming medical imaging standards.